In another study including 39 cell lines and 64 anti‐cancer drugs, AKR1B1 expression alteration induced the tumour cells to become more sensitive to 23 out of 64 drugs, suggesting that AKR1B1 expression could be a putative marker for chemosensitivity prediction.32 Here, AKR1B1 is linked to cancer.